Literature DB >> 10685985

Reproductive decisions after neonatal screening identifies cystic fibrosis.

T Dudding1, B Wilcken, B Burgess, J Hambly, G Turner.   

Abstract

AIMS: To document the reproductive choices made by women in New South Wales, Australia, after neonatal screening has identified cystic fibrosis (CF).
METHODS: A sample of women attending cystic fibrosis clinics in New South Wales who had a child (or children) diagnosed by neonatal screening between 1981 and 1996 were interviewed.
RESULTS: Two thirds of the women chose to avoid having another child with CF. The uptake of prenatal diagnosis was 66% in women who had a subsequent pregnancy; of these 69% terminated or would have terminated an affected fetus. Fifty nine per cent of the women who decided against a further pregnancy made this decision in order to avoid having another child with CF.
CONCLUSIONS: These data show that having a child with CF influenced subsequent reproductive choices. In addition to the medical advantages of an early diagnosis offered by neonatal screening, this also allows informed future reproductive decisions.

Entities:  

Mesh:

Year:  2000        PMID: 10685985      PMCID: PMC1721063          DOI: 10.1136/fn.82.2.f124

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  8 in total

1.  Convergence on the two-child family norm in Australia.

Authors:  A Y Adam
Journal:  J Aust Popul Assoc       Date:  1991-11

2.  Attitudes towards prenatal diagnosis and carrier screening for cystic fibrosis among the parents of patients in a paediatric cystic fibrosis clinic.

Authors:  E K Watson; J Marchant; A Bush; B Williamson
Journal:  J Med Genet       Date:  1992-07       Impact factor: 6.318

3.  Attitudes toward the prenatal diagnosis of cystic fibrosis: factors in decision making among affected families.

Authors:  D C Wertz; S R Janes; J M Rosenfield; R W Erbe
Journal:  Am J Hum Genet       Date:  1992-05       Impact factor: 11.025

4.  Neonatal screening for cystic fibrosis: a comparison of two strategies for case detection in 1.2 million babies.

Authors:  B Wilcken; V Wiley; G Sherry; U Bayliss
Journal:  J Pediatr       Date:  1995-12       Impact factor: 4.406

5.  Nutritional benefits of neonatal screening for cystic fibrosis. Wisconsin Cystic Fibrosis Neonatal Screening Study Group.

Authors:  P M Farrell; M R Kosorok; A Laxova; G Shen; R E Koscik; W T Bruns; M Splaingard; E H Mischler
Journal:  N Engl J Med       Date:  1997-10-02       Impact factor: 91.245

6.  Influence of five years of antenatal screening on the paediatric cystic fibrosis population in one region.

Authors:  S Cunningham; T Marshall
Journal:  Arch Dis Child       Date:  1998-04       Impact factor: 3.791

7.  Cystic fibrosis newborn screening: impact on reproductive behavior and implications for genetic counseling.

Authors:  E H Mischler; B S Wilfond; N Fost; A Laxova; C Reiser; C M Sauer; L M Makholm; G Shen; L Feenan; C McCarthy; P M Farrell
Journal:  Pediatrics       Date:  1998-07       Impact factor: 7.124

8.  A child with cystic fibrosis: II. Subsequent family planning decisions, reproduction and use of prenatal diagnosis.

Authors:  G Evers-Kiebooms; L Denayer; H Van den Berghe
Journal:  Clin Genet       Date:  1990-03       Impact factor: 4.438

  8 in total
  8 in total

1.  "Suddenly Having two Positive People who are Carriers is a Whole New Thing" - Experiences of Couples Both Identified as Carriers of Cystic Fibrosis Through a Population-Based Carrier Screening Program in Australia.

Authors:  Liane Ioannou; Martin B Delatycki; John Massie; Jan Hodgson; Sharon Lewis
Journal:  J Genet Couns       Date:  2015-05-01       Impact factor: 2.537

2.  Shock, adjust, decide: reproductive decision making in cystic fibrosis (CF) carrier couples--a qualitative study.

Authors:  Jessica Myring; William Beckett; Rupinder Jassi; Theresa Roberts; Richard Sayers; Diana Scotcher; Marion McAllister
Journal:  J Genet Couns       Date:  2011-04-05       Impact factor: 2.537

3.  Uptake of carrier testing in families after cystic fibrosis diagnosis through newborn screening.

Authors:  Belinda J McClaren; Sylvia A Metcalfe; Maryanne Aitken; R John Massie; Obioha C Ukoumunne; David J Amor
Journal:  Eur J Hum Genet       Date:  2010-05-26       Impact factor: 4.246

Review 4.  Newborn screening for cystic fibrosis: a lesson in public health disparities.

Authors:  Lainie Friedman Ross
Journal:  J Pediatr       Date:  2008-09       Impact factor: 4.406

5.  Non-invasive prenatal diagnosis for cystic fibrosis: detection of paternal mutations, exploration of patient preferences and cost analysis.

Authors:  Melissa Hill; Philip Twiss; Talitha I Verhoef; Suzanne Drury; Fiona McKay; Sarah Mason; Lucy Jenkins; Stephen Morris; Lyn S Chitty
Journal:  Prenat Diagn       Date:  2015-04-05       Impact factor: 3.050

6.  A secondary benefit: the reproductive impact of carrier results from newborn screening for cystic fibrosis.

Authors:  Yvonne Bombard; Fiona A Miller; Carolyn J Barg; Sarah J Patton; June C Carroll; Pranesh Chakraborty; Beth K Potter; Karen Tam; Louise Taylor; Elizabeth Kerr; Christine Davies; Jennifer Milburn; Felix Ratjen; Astrid Guttmann; Robin Z Hayeems
Journal:  Genet Med       Date:  2016-09-08       Impact factor: 8.822

7.  How do genetically disabled adults view selective reproduction? Impairment, identity, and genetic screening.

Authors:  Felicity K Boardman; Rachel Hale
Journal:  Mol Genet Genomic Med       Date:  2018-09-09       Impact factor: 2.183

8.  Preferences for Prenatal Tests for Cystic Fibrosis: A Discrete Choice Experiment to Compare the Views of Adult Patients, Carriers of Cystic Fibrosis and Health Professionals.

Authors:  Melissa Hill; Ranjan Suri; Edward F Nash; Stephen Morris; Lyn S Chitty
Journal:  J Clin Med       Date:  2014-02-14       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.